Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Three Things to Love About BP plc (ADR) (BP)

LONDON — There are things to love and loathe about most companies. Today, I’m going to tell you about three things to love about BP plc (ADR) (NYSE:BP).

I’ll also be asking whether these positive factors make the FTSE 100 oil supermajor a good investment today.

BP plc (ADR) (NYSE:BP)

Uncertainty can mean potential opportunity for investors. And uncertainty continues to surround BP plc (ADR) (NYSE:BP) more than three years after its Gulf of Mexico oil spill. While the company has already settled a lot of claims against it, there are more to come and the final cost is as yet unknown. BP plc (ADR) (NYSE:BP) says it is simply not possible to come up with “a reliable estimate” at this stage.

Another uncertainty hanging over the company — and other big oil groups, including Shell and Statoil ASA(ADR) (NYSE:STO) — is an investigation into allegations that firms colluded in fixing oil prices. Again, there is the possibility of BP plc (ADR) (NYSE:BP)taking a damaging financial hit.

At a recent share price of 446 pence — over 200 pence below the level before the oil spill — the current uncertainty makes BP plc (ADR) (NYSE:BP) an investment opportunity with a high risk but, potentially, a high reward.

There’s been a big shift in the nature of BP plc (ADR) (NYSE:BP)’s interests in Russia. TNK-BP, a venture with Russian oligarchs, was financially successful, but relations between the partners were fragile. However, BP recently disposed of its 50% share of TNK-BP — valued at $55 billion — ending up with a 20% stake in state-owned oil firm Rosneft and about $12 billion in cash.

The deal was sealed at the mansion of Russian president Vladimir Putin with whom the boss of Rosneft is on excellent terms. BP’s interest in what is the largest listed oil company in the world puts its exposure to the exciting Russian oil industry on a somewhat more solid footing — even if there remain risks of unfavorable changes in the political winds.

Earnings and dividend
It’s arguable that BP’s risks are more than priced in. At 446 pence, investors are paying just a bit over eight times current-year forecast earnings, falling to just a bit over seven times earnings for 2014.

As well as the low price-to-earnings (P/E) ratios, analysts are forecasting strong earnings growth of 40% this year and 12% next. That translates into attractive PEG (P/E-to-earnings growth) ratios of 0.2 and 0.6, respectively. A PEG of less than one is generally considered to be good value.

Similarly, the dividend is appealing: the prospective yield is 5.3%. Furthermore, the dividend has been growing strongly since being reinstated at a lower level after the Gulf of Mexico disaster, and analysts reckon the growth is set to continue: an 8% increase this year and 6% next.

A good investment?
For investors willing to take a higher risk for a potentially higher return, BP’s valuation makes it an interesting proposition. Shell has similar P/E and yield ratings, but BP’s forecast earnings and dividend growth are much superior.

The article 3 Things to Love About BP originally appeared on and is written by G.A. Chester.

G.A. Chester has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!